drugset / Trial / NCT01269866
Study of Duloxetine in the Reduction of Pain in Patient With Systemic Lupus Erythematosus
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to determine whether Duloxetine (cymbalta) can reduce pain severity in patient with Systemic Lupus Erythematosus.
Timeline
- Start
- 2010-12
- Primary completion
- 2012-05
- Completion
- 2012-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Duloxetine | Small molecule | 60 mg | Oral |
| Subject | Duloxetine | Small molecule | 120 mg | Oral |